MGTX
MeiraGTx Holdings plc

948
Mkt Cap
$701.88M
Volume
1.24M
52W High
$9.73
52W Low
$4.55
PE Ratio
-4.22
MGTX Fundamentals
Price
$8.92
Prev Close
$8.72
Open
$8.77
50D MA
$8.35
Beta
1.33
Avg. Volume
681,112.00
EPS (Annual)
-$2.12
P/B
-17.70
Rev/Employee
$87,346.46
Loading...
Loading...
MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
381

Frequently Asked Questions

What is Market Cap of MeiraGTx Holdings plc?
What is the 52-week high for MeiraGTx Holdings plc?
What is the 52-week low for MeiraGTx Holdings plc?
What is MeiraGTx Holdings plc stock price today?
What was MeiraGTx Holdings plc stock price yesterday?
What is the PE ratio of MeiraGTx Holdings plc?
What is the Price-to-Book ratio of MeiraGTx Holdings plc?
What is the 50-day moving average of MeiraGTx Holdings plc?
How many employess does MeiraGTx Holdings plc has?

Latest MGTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.